Insider · CIK 0001433254
Thomas Berquist
Files at QLYS (QUALYS, INC.), ASAN (Asana, Inc.). First filing Jun 16, 2025, latest Sep 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QLYS: QUALYS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | QUALYS, INC. | $90k 511 shares | -8% | +124% from low-13% from high | |
| 11Weak | QUALYS, INC. | $68k 512 shares | -9% | +16% from low-16% from high | |
| 24Weak | QUALYS, INC. | $91k 656 shares | -10% | +20% from low-13% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | ASAN Asana, Inc. | AGrant or award Class A Common Stock | +38,802 | $0.00 | $0 | 38,802 | 14 d ago |
| Sep 2, 2026 | QLYS QUALYS, INC. | SOpen-market sale Common Stock10b5-1 | -511 | $175.27 | $90k | 6,270 | 39 d ago |
| Sep 2, 2025 | QLYS QUALYS, INC. | SOpen-market sale Common Stock10b5-1 | -150 | $132.18 | $20k | 5,454 | Sep 3, 2025 |
| Sep 2, 2025 | QLYS QUALYS, INC. | SOpen-market sale Common Stock10b5-1 | -325 | $133.41 | $43k | 5,129 | Sep 3, 2025 |
| Sep 2, 2025 | QLYS QUALYS, INC. | SOpen-market sale Common Stock10b5-1 | -37 | $133.93 | $4,955 | 5,092 | Sep 3, 2025 |
| Jun 13, 2025 | QLYS QUALYS, INC. | SOpen-market sale Common Stock10b5-1 | -656 | $138.78 | $91k | 5,604 | Jun 16, 2025 |
| Jun 11, 2025 | QLYS QUALYS, INC. | AGrant or award Common Stock | +1,879 | $0.00 | $0 | 6,260 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.